Amgen to Buy Onyx Pharaceuticals for $10.4 Billion

Amgen to Buy Onyx Pharaceuticals for $10.4 Billion

Amgen via Bloomberg

Amgen Inc. said in a statement it will pay $125 per share for all of Onyx Pharmaceuticals Inc.’s shares outstanding.